IDEAYA Biosciences Inc.

NASDAQ: IDYA · Real-Time Price · USD
17.16
-0.29 (-1.66%)
At close: May 14, 2025, 3:59 PM
17.10
-0.35%
After-hours: May 14, 2025, 07:14 PM EDT

IDEAYA Biosciences Revenue Breakdown

Period Ending Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Methionine Adenosyl Transferase2 A Program Supply Revenue 2.4M 2.41M 2.35M
Methionine Adenosyl Transferase2 A Program Supply Revenue Growth -0.46% +2.55% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selling, General, and Administrative Revenue 13.5M 10.96M 9.74M 9.3M 8.21M 7.07M 7.86M 7.08M 6.3M 5.75M 6.67M 5.55M 5.92M 5.22M 5.19M 4.83M 4.82M 3.8M 3.94M 3.99M 3.45M 2.78M 2.7M 2.38M 2.1M 1.56M 1.09M 1.14M 885K
Selling, General, and Administrative Revenue Growth +23.26% +12.46% +4.78% +13.21% +16.19% -10.11% +11.14% +12.30% +9.53% -13.72% +20.04% -6.23% +13.40% +0.71% +7.42% +0.25% +26.74% -3.53% -1.38% +15.70% +24.26% +2.89% +13.64% +13.25% +34.83% +43.01% -4.48% +28.70% n/a
Research and Development Revenue 70.89M 140.18M 57.15M 54.53M 42.8M 38.77M 33.7M 29.18M 27.86M 24.71M 22.37M 22.8M 19.66M 16.11M 15.5M 14.98M 11.57M 12.05M 10.02M 8.6M 9.03M 8.54M 8.92M 8.86M 8M 7.58M 12.54M 6.43M 5.2M
Research and Development Revenue Growth -49.43% +145.28% +4.80% +27.40% +10.41% +15.04% +15.50% +4.73% +12.73% +10.47% -1.86% +15.97% +22.02% +3.91% +3.50% +29.51% -4.02% +20.22% +16.61% -4.76% +5.68% -4.28% +0.72% +10.79% +5.53% -39.57% +94.93% +23.64% n/a